English

AQUILA BIOPHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2000-11-13

24 filing records in this dataset, filed from 1995-05-01 to 2000-11-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.44 million USD

2000-03-31 · USD

Exact inputs and evidence

Revenue: 1442000 USD Source

Cash and cash equivalents: 1.97 million USD 2000-09-30 Source
Exact value

1972000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-7.25 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Operating cash flow: -3413986 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: -2305000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -2392000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -4995000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -2392000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -6141000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -4995000 USD · 1999-01-01 – 1999-06-30 Source

Capital expenditure

3.99 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Capital expenditure: 5968118 USD · 1998-01-01 – 1998-12-31 Source
Capital expenditure: 2508000 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 181000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 245000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 181000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 527000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 245000 USD · 1999-01-01 – 1999-06-30 Source

Free cash flow

-11.2 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Operating cash flow: -3413986 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: -2305000 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -2392000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -4995000 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -2392000 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -6141000 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -4995000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 5968118 USD · 1998-01-01 – 1998-12-31 Source
Capital expenditure: 2508000 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 181000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 245000 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 181000 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 527000 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 245000 USD · 1999-01-01 – 1999-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-11-13.

Financial data available through: 1998-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 1998-12-31
Operating income: 5 of 11 periods available· newest 1998-12-31
Net income: 5 of 11 periods available· newest 1998-12-31
Operating cash flow: 5 of 11 periods available· newest 1998-12-31
Capital expenditure: 5 of 11 periods available· newest 1998-12-31
Total assets: 5 of 11 periods available· newest 1998-12-31
Total liabilities: 5 of 11 periods available· newest 1998-12-31
Current assets: 5 of 11 periods available· newest 1998-12-31
Current liabilities: 5 of 11 periods available· newest 1998-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 1998-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-19.2%

Prior period

USD 6.93 million

1997-01-01 – 1997-12-31
Current period

USD 5.6 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

5597409 − 6928237 = -1330828 USD

6928237 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
5597409 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Year-over-year change in Revenue: -1330828 USD Concept: fundies:Revenue Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 5597409 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1810 Input fundies:Revenue: 6928237 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1810
The citation records this snapshot. The page link may show a newer release later.
Net income
-1,677.5%

Prior period

USD 925,516

1997-01-01 – 1997-12-31
Current period

−USD 14.6 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

-14599635 − 925516 = -15525151 USD

925516 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-14599635 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Year-over-year change in Net income: -15525151 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -14599635 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1958 Input fundies:NetIncome: 925516 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1958
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 431,357

Prior period

−USD 2.98 million

1997-01-01 – 1997-12-31
Current period

−USD 3.41 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

-3413986 − -2982629 = -431357 USD

-2982629 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-3413986 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Year-over-year change in Operating cash flow: -431357 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3413986 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981 Input fundies:OperatingCashFlow: -2982629 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+1,507.9%

Prior period

USD 371,176

1997-01-01 – 1997-12-31
Current period

USD 5.97 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

5968118 − 371176 = 5596942 USD

371176 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
5968118 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Year-over-year change in Capital expenditure: 5596942 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5968118 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987 Input fundies:CapitalExpenditure: 371176 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1998-01-01 – 1998-12-31

Revenue USD 5.6 million 100% of revenue
Operating costs Derived USD 5.6 million 100% of revenue
Operating income USD 0 0% of revenue
Tax, interest and other Derived USD 14.6 million 261% of revenue
Net income −USD 14.6 million −261% of revenue

Cash

Operating cash flow −USD 3.41 million −61% of revenue
Capital expenditure USD 5.97 million 107% of revenue
Free cash flow Derived −USD 9.38 million −168% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 110% of revenue.
1995 Net loss: net income was −86% of revenue.
1996 Net income was higher than operating income, so the split is not drawn.
1997 Net income was higher than operating income, so the split is not drawn.
1998 Net loss: net income was −261% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	22099859	24361823 Derived	-2261964	20014302 Derived	-22276266	-5213297 Derived	Source 1994-01-01 – 1994-12-31: 22099859 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -2261964 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -22276266 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -3094938 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 2118359 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	5727716	5504386 Derived	223330	5164876 Derived	-4941546	-1473371 Derived	Source 1995-01-01 – 1995-12-31: 5727716 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: 223330 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -4941546 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -879820 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 593551 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	6573112	5120302 Derived	1452810	-4506721 Derived	5959531	-1396957 Derived	Source 1996-01-01 – 1996-12-31: 6573112 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: 1452810 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: 5959531 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -1087330 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 309627 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	6928237	6928237 Derived	0	-925516 Derived	925516	-3353805 Derived	Source 1997-01-01 – 1997-12-31: 6928237 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: 0 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: 925516 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -2982629 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 371176 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	5597409	5597409 Derived	0	14599635 Derived	-14599635	-9382104 Derived	Source 1998-01-01 – 1998-12-31: 5597409 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 0 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -14599635 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -3413986 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 5968118 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 5.6M 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	22099859	Revenue: 22099859 Open source
19951995-12-31	Revenue	5727716	Revenue: 5727716 Open source
19961996-12-31	Revenue	6573112	Revenue: 6573112 Open source
19971997-12-31	Revenue	6928237	Revenue: 6928237 Open source
19981998-12-31	Revenue	5597409	Revenue: 5597409 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-19.2% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 22099859 Open source
19951995-12-31	Year over year	-74.1%	Revenue: 5727716 Open source Revenue: 22099859 Open source
19961996-12-31	Year over year	14.8%	Revenue: 6573112 Open source Revenue: 5727716 Open source
19971997-12-31	Year over year	5.4%	Revenue: 6928237 Open source Revenue: 6573112 Open source
19981998-12-31	Year over year	-19.2%	Revenue: 5597409 Open source Revenue: 6928237 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0% 1998

Net margin -260.8% 1998

Free cash flow margin -167.6% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	-10.2%	Operating Income: -2261964 Open source Revenue: 22099859 Open source
19951995-12-31	Operating margin	3.9%	Operating Income: 223330 Open source Revenue: 5727716 Open source
19961996-12-31	Operating margin	22.1%	Operating Income: 1452810 Open source Revenue: 6573112 Open source
19971997-12-31	Operating margin	0%	Operating Income: 0 Open source Revenue: 6928237 Open source
19981998-12-31	Operating margin	0%	Operating Income: 0 Open source Revenue: 5597409 Open source
19941994-12-31	Net margin	-100.8%	Net Income: -22276266 Open source Revenue: 22099859 Open source
19951995-12-31	Net margin	-86.3%	Net Income: -4941546 Open source Revenue: 5727716 Open source
19961996-12-31	Net margin	90.7%	Net Income: 5959531 Open source Revenue: 6573112 Open source
19971997-12-31	Net margin	13.4%	Net Income: 925516 Open source Revenue: 6928237 Open source
19981998-12-31	Net margin	-260.8%	Net Income: -14599635 Open source Revenue: 5597409 Open source
19941994-12-31	Free cash flow margin	-23.6%	Revenue: 22099859 Open source Operating Cash Flow: -3094938 Open source Capital Expenditure: 2118359 Open source
19951995-12-31	Free cash flow margin	-25.7%	Revenue: 5727716 Open source Operating Cash Flow: -879820 Open source Capital Expenditure: 593551 Open source
19961996-12-31	Free cash flow margin	-21.3%	Revenue: 6573112 Open source Operating Cash Flow: -1087330 Open source Capital Expenditure: 309627 Open source
19971997-12-31	Free cash flow margin	-48.4%	Revenue: 6928237 Open source Operating Cash Flow: -2982629 Open source Capital Expenditure: 371176 Open source
19981998-12-31	Free cash flow margin	-167.6%	Revenue: 5597409 Open source Operating Cash Flow: -3413986 Open source Capital Expenditure: 5968118 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.4M 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-3094938	Operating Cash Flow: -3094938 Open source
19951995-12-31	Operating cash flow	-879820	Operating Cash Flow: -879820 Open source
19961996-12-31	Operating cash flow	-1087330	Operating Cash Flow: -1087330 Open source
19971997-12-31	Operating cash flow	-2982629	Operating Cash Flow: -2982629 Open source
19981998-12-31	Operating cash flow	-3413986	Operating Cash Flow: -3413986 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -9.4M 1998

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-5213297	Operating Cash Flow: -3094938 Open source Capital Expenditure: 2118359 Open source
19951995-12-31	Free cash flow	-1473371	Operating Cash Flow: -879820 Open source Capital Expenditure: 593551 Open source
19961996-12-31	Free cash flow	-1396957	Operating Cash Flow: -1087330 Open source Capital Expenditure: 309627 Open source
19971997-12-31	Free cash flow	-3353805	Operating Cash Flow: -2982629 Open source Capital Expenditure: 371176 Open source
19981998-12-31	Free cash flow	-9382104	Operating Cash Flow: -3413986 Open source Capital Expenditure: 5968118 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

36.4% 1998

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Liabilities / assets	69.6%	Total Liabilities: 19835000 Open source Total Assets: 28503000 Open source
19951995-12-31	Liabilities / assets	82.8%	Total Liabilities: 19090074 Open source Total Assets: 23044579 Open source
19961996-12-31	Liabilities / assets	35.7%	Total Liabilities: 9395033 Open source Total Assets: 26312350 Open source
19971997-12-31	Liabilities / assets	13.5%	Total Liabilities: 2780757 Open source Total Assets: 20667461 Open source
19981998-12-31	Liabilities / assets	36.4%	Total Liabilities: 8975403 Open source Total Assets: 24628399 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.34× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Current assets / current liabilities	2.2×	Current Assets: 16308000 Open source Current Liabilities: 7422000 Open source
19951995-12-31	Current assets / current liabilities	2.15×	Current Assets: 14899054 Open source Current Liabilities: 6922450 Open source
19961996-12-31	Current assets / current liabilities	4.16×	Current Assets: 21270741 Open source Current Liabilities: 5114469 Open source
19971997-12-31	Current assets / current liabilities	7.63×	Current Assets: 18445750 Open source Current Liabilities: 2417079 Open source
19981998-12-31	Current assets / current liabilities	3.34×	Current Assets: 16971558 Open source Current Liabilities: 5080909 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 22.28 million Exact value Exact value: -22276266 USD 1994-01-01 – 1994-12-31: -22276266 USD Inspect Net Income Open source Share or cite Citation for Net Income · AQUILA BIOPHARMACEUTICALS INC · 1994-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Net Income: -22276266 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22276266 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-96-000015.txt#3500 The citation records this snapshot. The page link may show a newer release later.	−USD 3.09 million Exact value Exact value: -3094938 USD 1994-01-01 – 1994-12-31: -3094938 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AQUILA BIOPHARMACEUTICALS INC · 1994-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Operating Cash Flow: -3094938 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3094938 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-96-000015.txt#3531 The citation records this snapshot. The page link may show a newer release later.	USD 2.12 million Exact value Exact value: 2118359 USD 1994-01-01 – 1994-12-31: 2118359 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AQUILA BIOPHARMACEUTICALS INC · 1994-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Capital Expenditure: 2118359 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2118359 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-96-000015.txt#3539 The citation records this snapshot. The page link may show a newer release later.	−USD 5.21 million Calculation and evidence -3094938 − 2118359 USD Exact free cash flow: -5213297 USD 1994-01-01 – 1994-12-31: -3094938 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 2118359 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AQUILA BIOPHARMACEUTICALS INC · 1994-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Free cash flow: -5213297 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3094938 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-96-000015.txt#3531 Input fundies:CapitalExpenditure: 2118359 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-96-000015.txt#3539 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 4.94 million Exact value Exact value: -4941546 USD 1995-01-01 – 1995-12-31: -4941546 USD Inspect Net Income Open source Share or cite Citation for Net Income · AQUILA BIOPHARMACEUTICALS INC · 1995-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Net Income: -4941546 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4941546 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-98-000011.txt#2207 The citation records this snapshot. The page link may show a newer release later.	−USD 879,820 Exact value Exact value: -879820 USD 1995-01-01 – 1995-12-31: -879820 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AQUILA BIOPHARMACEUTICALS INC · 1995-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Operating Cash Flow: -879820 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -879820 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-97-000007.txt#2351 The citation records this snapshot. The page link may show a newer release later.	USD 593,551 Exact value Exact value: 593551 USD 1995-01-01 – 1995-12-31: 593551 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AQUILA BIOPHARMACEUTICALS INC · 1995-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Capital Expenditure: 593551 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 593551 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-97-000007.txt#2358 The citation records this snapshot. The page link may show a newer release later.	−USD 1.47 million Calculation and evidence -879820 − 593551 USD Exact free cash flow: -1473371 USD 1995-01-01 – 1995-12-31: -879820 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 593551 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AQUILA BIOPHARMACEUTICALS INC · 1995-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Free cash flow: -1473371 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -879820 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-97-000007.txt#2351 Input fundies:CapitalExpenditure: 593551 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-97-000007.txt#2358 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	USD 5.96 million Exact value Exact value: 5959531 USD 1996-01-01 – 1996-12-31: 5959531 USD Inspect Net Income Open source Share or cite Citation for Net Income · AQUILA BIOPHARMACEUTICALS INC · 1996-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Net Income: 5959531 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5959531 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1958 The citation records this snapshot. The page link may show a newer release later.	−USD 1.09 million Exact value Exact value: -1087330 USD 1996-01-01 – 1996-12-31: -1087330 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AQUILA BIOPHARMACEUTICALS INC · 1996-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Operating Cash Flow: -1087330 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1087330 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981 The citation records this snapshot. The page link may show a newer release later.	USD 309,627 Exact value Exact value: 309627 USD 1996-01-01 – 1996-12-31: 309627 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AQUILA BIOPHARMACEUTICALS INC · 1996-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Capital Expenditure: 309627 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 309627 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987 The citation records this snapshot. The page link may show a newer release later.	−USD 1.4 million Calculation and evidence -1087330 − 309627 USD Exact free cash flow: -1396957 USD 1996-01-01 – 1996-12-31: -1087330 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 309627 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AQUILA BIOPHARMACEUTICALS INC · 1996-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Free cash flow: -1396957 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1087330 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981 Input fundies:CapitalExpenditure: 309627 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	USD 925,516 Exact value Exact value: 925516 USD 1997-01-01 – 1997-12-31: 925516 USD Inspect Net Income Open source Share or cite Citation for Net Income · AQUILA BIOPHARMACEUTICALS INC · 1997-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Net Income: 925516 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 925516 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1958 The citation records this snapshot. The page link may show a newer release later.	−USD 2.98 million Exact value Exact value: -2982629 USD 1997-01-01 – 1997-12-31: -2982629 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AQUILA BIOPHARMACEUTICALS INC · 1997-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Operating Cash Flow: -2982629 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2982629 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981 The citation records this snapshot. The page link may show a newer release later.	USD 371,176 Exact value Exact value: 371176 USD 1997-01-01 – 1997-12-31: 371176 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AQUILA BIOPHARMACEUTICALS INC · 1997-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Capital Expenditure: 371176 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 371176 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987 The citation records this snapshot. The page link may show a newer release later.	−USD 3.35 million Calculation and evidence -2982629 − 371176 USD Exact free cash flow: -3353805 USD 1997-01-01 – 1997-12-31: -2982629 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 371176 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AQUILA BIOPHARMACEUTICALS INC · 1997-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Free cash flow: -3353805 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2982629 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981 Input fundies:CapitalExpenditure: 371176 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 14.6 million Exact value Exact value: -14599635 USD 1998-01-01 – 1998-12-31: -14599635 USD Inspect Net Income Open source Share or cite Citation for Net Income · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Net Income: -14599635 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14599635 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1958 The citation records this snapshot. The page link may show a newer release later.	−USD 3.41 million Exact value Exact value: -3413986 USD 1998-01-01 – 1998-12-31: -3413986 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Operating Cash Flow: -3413986 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3413986 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981 The citation records this snapshot. The page link may show a newer release later.	USD 5.97 million Exact value Exact value: 5968118 USD 1998-01-01 – 1998-12-31: 5968118 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Capital Expenditure: 5968118 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5968118 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987 The citation records this snapshot. The page link may show a newer release later.	−USD 9.38 million Calculation and evidence -3413986 − 5968118 USD Exact free cash flow: -9382104 USD 1998-01-01 – 1998-12-31: -3413986 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 5968118 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AQUILA BIOPHARMACEUTICALS INC · 1998-12-31 AQUILA BIOPHARMACEUTICALS INC (edgar:704292) Free cash flow: -9382104 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:55:43Z Snapshot: eb5deeddd334cdd9329b5b33f4cdfb503e72ec1c39cf2da897e0042e899eb522 Dimensions: Consolidated View: https://fundies.io/companies/edgar/704292?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3413986 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1981 Input fundies:CapitalExpenditure: 5968118 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/704292/0000942794-99-000006.txt#1987 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000704292, 704292, edgar:704292

Also known as CAMBRIDGE BIOTECH CORP

AQUILA BIOPHARMACEUTICALS INC

Latest quarter

Revenue

Trailing twelve months

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1998 1998-01-01 – 1998-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation